Home
Paradigm Biocapital Advisors reported a 3.3% stake in Erasca ERAS · 10,392,702 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 3.3%
- Last report
- 5.3% · filed 26/01/14
- Shares held
- 10,392,702 sh
- Class
- Common Stock, $0.0001 par value per share
- Stock
- Erasca ERAS
- Event date
- 26/03/31
- Filed
- 26/05/15
3.3% stake · below 5%
- Stake
- 3.3%
- Last report
- 5.3%
- Since last report
- −2.0pp
Erasca trades, last 26 weeks
What else happened in Erasca around then
Filed or reported within 30 days of the trade day · 03/01~04/30Paradigm Biocapital Advisors's other 5% stake reports
- Paradigm Biocapital Advisors
5% stakeSpyre Therapeutics
5% stakeSpyre Therapeutics
SYRE
5.1% stake
4,457,450 sh
5.1% stake
Filed 10/01
- Paradigm Biocapital Advisors
5% stakeTyra Biosciences
5% stakeTyra Biosciences
TYRA
5.8% stake
3,473,453 sh
5.8% stake
Filed 09/17
- Paradigm Biocapital Advisors
5% stakeAssembly Biosciences
5% stakeAssembly Biosciences
ASMB
7.8% stake
1,553,748 sh
7.8% stake
Filed 08/14
- Paradigm Biocapital Advisors
5% stakeViridian Therapeutics, Inc.\DE
5% stakeViridian Therapeutics, Inc.\DE
VRDN
6.1% stake
6,723,788 sh
6.1% stake
Filed 08/14
- Paradigm Biocapital Advisors
5% stakeLexeo Therapeutics
5% stakeLexeo Therapeutics
LXEO
5.3% stake
4,175,382 sh
5.3% stake
Filed 08/14
